On March 17, 2026, NPR reported that Title X — the 56-year-old federal program providing free birth control, STI testing, and cancer screenings to low-income patients — faces an imminent funding cliff on March 31. For the first time in 27 years, the application guidance for grant renewals was never released on its December 31, 2025 deadline. When applications finally opened on March 14, grantees were given just one week to submit comprehensive materials — a process that normally takes three to four months.

Why It Matters

Title X is the backbone of reproductive and sexual health access for millions of low-income Americans. A funding disruption would ripple directly through STI testing availability, contraception access, and cancer screening capacity — all core services that intersect with the sexual wellness industry's mission of accessible sexual health. For femtech and sexual health startups that partner with or complement public health infrastructure, the stability of Title X is a baseline assumption. Its potential collapse creates both a crisis and, perversely, a market opportunity for private-sector alternatives.

Clare Coleman, president of the National Family Planning and Reproductive Health Association, called the timeline "laughable," noting that just 10 HHS staffers have seven business days to review dozens of applications covering thousands of clinics nationwide. A total of 128 Democratic members of Congress, organized through the House Democratic Women's Caucus and Reproductive Freedom Caucus, signed a letter urging Health Secretary Robert F. Kennedy Jr. to grant a one-year full funding extension to all current Title X grantees.

The funding crisis caps a turbulent period for the program. The Trump administration had withheld 22 Title X grants for most of 2025 before a lawsuit forced their release, and the entire Title X administration staff was fired during the October 2025 government shutdown. Even brief funding gaps could force health centers to reduce hours, lay off staff, or eliminate services entirely — directly impacting communities that depend on Title X for birth control access, STI testing and treatment, and cancer screenings.

Sources


Update — 2026-03-28

Initial entry — story first created.